Misti Hedgepeth, NPC

Misti Hedgepeth practices at Southwest Mississippi Regional Medical Center - Mammography in Mccomb, Mississippi.

Misti Hedgepeth's NPI, 1649753039, was assigned on September 11, 2018. Misti Hedgepeth holds Mississippi license 902897.

Misti Hedgepeth's primary practice is Southwest Mississippi Regional Medical Center - Mammography, at 215 Marion Ave., Mccomb, MS 39648. The practice phone is (601) 249-5197.

Misti Hedgepeth's primary practice is Southwest Mississippi Regional Medical Center - Mammography in Mccomb, Mississippi. Misti Hedgepeth is also affiliated with Southwest Mississippi Regional Medical Center. The medical group on file is Lawrence County Primary Care. Dmand AI also links Misti Hedgepeth to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Misti Hedgepeth practices, 4 sites in all. Vendor and product names are available with a free account.

Nurse practitioner is Misti Hedgepeth's primary specialty in the NPI Registry, under taxonomy code 363L00000X. Misti Hedgepeth is licensed in Mississippi.

CMS counts 431 Medicare patients who saw Misti Hedgepeth in 2024. The largest group is 65 to 74, with 171 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 23% are also on Medicaid. Their average risk score is 1.69, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Misti Hedgepeth's median patient age at 67, with 63% women.

In 2024, Misti Hedgepeth wrote 2,380 Medicare Part D claims for 401 patients. 78% of them were for generic drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Misti Hedgepeth for performance year 2024, reported through an alternative payment model (APM). Misti Hedgepeth accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 60 general payments to Misti Hedgepeth from 27 drug and device companies in 2025. Food and beverage make up the largest share, 96% of the total. AstraZeneca Pharmaceuticals LP paid the most, $133.